ATE449177T1 - Staphylococcus epidermidis antigene - Google Patents
Staphylococcus epidermidis antigeneInfo
- Publication number
- ATE449177T1 ATE449177T1 AT04724557T AT04724557T ATE449177T1 AT E449177 T1 ATE449177 T1 AT E449177T1 AT 04724557 T AT04724557 T AT 04724557T AT 04724557 T AT04724557 T AT 04724557T AT E449177 T1 ATE449177 T1 AT E449177T1
- Authority
- AT
- Austria
- Prior art keywords
- antigens
- staphylococcus epidermidis
- epidermidis antigens
- hyperimmune serum
- serum reactive
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 241000191963 Staphylococcus epidermidis Species 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 230000000521 hyperimmunizing effect Effects 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03450078 | 2003-03-31 | ||
| PCT/EP2004/003398 WO2004087746A2 (en) | 2003-03-31 | 2004-03-31 | Staphylococcus epidermidis antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE449177T1 true ATE449177T1 (de) | 2009-12-15 |
Family
ID=33104246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04724557T ATE449177T1 (de) | 2003-03-31 | 2004-03-31 | Staphylococcus epidermidis antigene |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US7628994B2 (de) |
| EP (2) | EP2182065A3 (de) |
| JP (1) | JP2007523609A (de) |
| AT (1) | ATE449177T1 (de) |
| AU (1) | AU2004226262A1 (de) |
| CA (1) | CA2520868A1 (de) |
| DE (1) | DE602004024179D1 (de) |
| WO (1) | WO2004087746A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7628994B2 (en) | 2003-03-31 | 2009-12-08 | Intercell Ag | S. epidermidis antigens |
| DE602004031836D1 (de) * | 2003-07-08 | 2011-04-28 | Umc Utrecht Holding Bv | Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten |
| EP2340848A3 (de) * | 2004-10-21 | 2011-09-14 | Wyeth LLC | Immunogene Zusammensetzungen von Staphylococcus epidermidis Polypeptide und Polynucleotide Antigenen |
| NZ565069A (en) * | 2005-06-13 | 2011-08-26 | Glaxosmithkline Biolog Sa | Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| WO2008140632A2 (en) | 2007-01-24 | 2008-11-20 | Merck & Co., Inc. | Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| EP1980269A1 (de) * | 2007-04-13 | 2008-10-15 | Katholieke Universiteit Leuven | Prävention von Staphylokokken-Biofilmbildung |
| SG176837A1 (en) | 2009-06-22 | 2012-01-30 | Wyeth Llc | Immunogenic compositions of staphylococcus aureus antigens |
| WO2013184900A2 (en) * | 2012-06-06 | 2013-12-12 | Sanofi Pasteur Biologics, Llc | Immunogenic compositions and related methods |
| ITNA20120046A1 (it) * | 2012-08-02 | 2014-02-03 | No Self S R L | Uso di acidi nucleici di sistemi biologici parassiti, patogeni e infestanti per l'inibizione e/o controllo degli stessi sistemi |
| NL2022581B1 (en) * | 2019-02-14 | 2020-08-27 | Koppert Bv | Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| DK0533838T3 (da) | 1990-06-11 | 1998-02-23 | Nexstar Pharmaceuticals Inc | Nukleinsyreligander |
| ATE420171T1 (de) | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| RS50101B (sr) | 1996-02-24 | 2009-01-22 | Boehringer Ingelheim International Gmbh., | Farmaceutski preparati za imunomodulaciju |
| ES2188985T3 (es) | 1996-08-30 | 2003-07-01 | Jens Peter Furste | Seleccion enantiomerica y evolucion enantiomerica de acidos nucleicos. |
| US5989912A (en) | 1996-11-21 | 1999-11-23 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| US5849902A (en) | 1996-09-26 | 1998-12-15 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| DE19803453A1 (de) | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| EP2275553B1 (de) * | 1999-10-29 | 2015-05-13 | Novartis Vaccines and Diagnostics S.r.l. | Antigenpeptide aus Neisseria |
| WO2001034809A2 (en) * | 1999-11-09 | 2001-05-17 | Glaxo Group Limited | Staphylococcus epidermidis nucleic acids and proteins |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| ATE375169T1 (de) | 2000-04-14 | 2007-10-15 | Intercell Ag | Modifizierte peptide enthaltende pharmazeutische präparationen |
| RU2293573C2 (ru) | 2000-06-08 | 2007-02-20 | Интерселл Аг | Иммуностимулирующие олигодезоксинуклеотиды |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| US20040170642A1 (en) | 2000-08-17 | 2004-09-02 | Jorg Fritiz | Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof |
| JP4097178B2 (ja) * | 2000-10-03 | 2008-06-11 | 株式会社グリーンペプタイド | 腫瘍抗原 |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| WO2003011899A2 (en) * | 2001-08-02 | 2003-02-13 | University Of Sheffield | Antigenic polypeptides |
| CA2498784A1 (en) * | 2002-09-13 | 2004-03-25 | The Texas A & M University System | Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| US7628994B2 (en) | 2003-03-31 | 2009-12-08 | Intercell Ag | S. epidermidis antigens |
-
2004
- 2004-03-31 US US10/551,492 patent/US7628994B2/en not_active Expired - Fee Related
- 2004-03-31 AT AT04724557T patent/ATE449177T1/de not_active IP Right Cessation
- 2004-03-31 DE DE602004024179T patent/DE602004024179D1/de not_active Expired - Lifetime
- 2004-03-31 EP EP09173794A patent/EP2182065A3/de not_active Ceased
- 2004-03-31 AU AU2004226262A patent/AU2004226262A1/en not_active Abandoned
- 2004-03-31 WO PCT/EP2004/003398 patent/WO2004087746A2/en not_active Ceased
- 2004-03-31 JP JP2006504930A patent/JP2007523609A/ja not_active Withdrawn
- 2004-03-31 EP EP04724557A patent/EP1608756B1/de not_active Expired - Lifetime
- 2004-03-31 CA CA002520868A patent/CA2520868A1/en not_active Abandoned
-
2009
- 2009-11-24 US US12/625,053 patent/US8236325B2/en not_active Expired - Fee Related
-
2012
- 2012-07-03 US US13/540,696 patent/US8372410B2/en not_active Expired - Fee Related
-
2013
- 2013-01-09 US US13/737,228 patent/US20130122030A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070036778A1 (en) | 2007-02-15 |
| US20120269843A1 (en) | 2012-10-25 |
| EP2182065A3 (de) | 2010-09-15 |
| CA2520868A1 (en) | 2004-10-14 |
| JP2007523609A (ja) | 2007-08-23 |
| US8372410B2 (en) | 2013-02-12 |
| WO2004087746A2 (en) | 2004-10-14 |
| US8236325B2 (en) | 2012-08-07 |
| EP1608756A2 (de) | 2005-12-28 |
| WO2004087746A3 (en) | 2005-04-21 |
| DE602004024179D1 (de) | 2009-12-31 |
| US20130122030A1 (en) | 2013-05-16 |
| AU2004226262A1 (en) | 2004-10-14 |
| US7628994B2 (en) | 2009-12-08 |
| EP2182065A2 (de) | 2010-05-05 |
| US20100297162A1 (en) | 2010-11-25 |
| EP1608756B1 (de) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE441715T1 (de) | Streptococcus pyogenes antigene | |
| WO2004092209A3 (en) | S. pneumoniae antigens | |
| WO2005103073A3 (en) | Td antigens | |
| WO2004099242A3 (en) | Streptococcus agalactiae antigens i + ii | |
| ZA200800555B (en) | IL-1² binding antibodies and fragments thereof | |
| ATE554107T1 (de) | Als therapeutika geeignete monovalente antikörperfragmente | |
| WO2002062850A3 (en) | Hybrid antibodies and uses thereof | |
| IN2009KN02655A (de) | ||
| WO2007022520A3 (en) | Antibody-mediated enhancement of immune response | |
| BRPI0411854A (pt) | veìculos protéicos para vacinas | |
| WO2004074455A3 (en) | Fc REGION VARIANTS | |
| NO20054836L (no) | Nogo-reseptorbindingsprotein | |
| WO2002075274A3 (fr) | Methode et trousse pour le suivi des maladies neurodegeneratives | |
| WO2004106367A3 (en) | Enterococcus antigens | |
| WO2004029072A3 (en) | PrPsc -INTERACTING MOLECULES AND USES THEREOF | |
| ATE449177T1 (de) | Staphylococcus epidermidis antigene | |
| WO2004094467A3 (en) | H. pylori antigens | |
| WO2004046314A3 (en) | Methods for detecting asymmetric dimethylarginine in a biological sample | |
| ATE477274T1 (de) | Gegen clostridium difficile gerichtete antikörper | |
| WO2001066752A3 (en) | Reproduction-specific genes | |
| WO2004113374A3 (en) | Chlamydia pneumoniae antigens | |
| WO2007011776A3 (en) | Pamps, pathogen associated molecular patterns | |
| CY1117395T1 (el) | Il-1βητα δεσμευτικα αντισωματα και θραυσματα αυτων |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |